演讲嘉宾/Speakers

近40位来自中国及国际知名生命科学行业公司、律师事务所、投资商的高层管理人将带来大量行业最新动态信息、交流专业知识和深刻见解，分享宝贵成功经验并针对中国的新兴生物技术产业进行深入分析和如何在中国建立一个成功的生命科学公司发表独到见解。(点击这里查看 演讲人介绍)

欢迎致辞：

• Carola Schropp, MBA, MTS - President & Founder, EBD Group
• Greg B. Scott - President & Founder, ChinaBio^® LLC
• Barry Yang - Chairman, Suzhou Industrial Park
• Yuwen Liu, MBA - Chairwoman & CEO, BioBay

主题演讲人:

中国的合作景况：与变化同步

• David Chen, MD, MBA - Executive Vice President & COO, 3SBio Inc.
• Edward Hu, MBA - COO, WuXi AppTec
• Kewen Jin, PhD - General Manager, Charles River Greater China
• Xin Ma, PhD - Head of Global Drug Discovery-Innovation Center China, Bayer Schering Pharma
• Greg Wiederrecht, PhD, CLP - VP & Head, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories

演讲嘉宾和研讨嘉宾：

• Brian Cunningham, JD - Senior Counsel and Co-chair of Life Science Group, Morrison & Foerster LLP
• Jie Liu D’Elia, PhD, MBA - VP, International Business Development, Simcere Pharma
• Alex Fowkes, JD - Executive Director, Head of R&D Business Development, Pfizer Inc.
• Michael Heerde, PhD, MBA - Director, Strategy and Business Development, Bayer Healthcare China
• Ruediger Herrmann, PhD - Partner, WilmerHale
• Avery Ince, MD, PhD - Medical Director, MSD China
• Shawn Shiqing Li, JD, PhD - Associate, Blank Rome, LLP
• Esther H. Lim, JD - Founding Managing Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Shanghai Office
• Martina Molsbergen - CEO, C14 Consulting Group, LLC
• John V. Oyler, MBA - former CEO, BioDuro, Inc.
• Rajesh Parekh, PhD - Director, Head of Asia Healthcare Practice, McKinsey & Company
• Eric Pierce - Publisher, BioCentury
• J. Robert (Bob) Powell, PharmD - Scientific Advisor, Roche (China) Holding Ltd.
• Jianzhong (David) Shen, JD, PhD - Asia Regional IP Counsel, Eli Lilly
• Maria Song, PhD, MD - President, VPS-CRO Group
• Howard Sui, PhD, MBA - Managing Director, Merck Serono China
• Julian Thurston - Partner and Co-chair of Life Sciences Department, Morrison & Foerster LLP, UK
• Breaux Walker - Managing Director, JMP Securities LLC
• Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia
• Ningling Wang, JD - Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Shanghai Office
• Richard Wang, PhD, MBA - Director, Strategic Alliance and Collaboration, AstraZeneca
• Xiaochuan Wang, PhD - Chairman & CEO, Sundia MediTech Co., Ltd.
• Huacheng Wei, PhD - President, Beijing Pharmaceutical Group Co., Ltd.
• Jimmy Wei, PhD, MBA - Senior Vice President, Business Development and Corporate Planning, Hutchison MediPhama Limited
• Ian Wisenberg - Senior Vice President, Strategic Development, ChinaBio^® LLC
• Xiaobing Wu, PhD - General Manager, Pfizer China
• Dajun Yang, MD, PhD - Co-Founder, President & CEO, Ascentage Pharma
• Yanning Yi, MBA - Executive Director, The Balloch Group
• Alfred W. Zaher, JD - Partner, Blank Rome LLP
• Dan Zhang, MD, MPH - Chairman & CEO, Fountain Medical Development Ltd.
• Ian Zhang - Head of Corporate Development, Asia Pacific, Life Technologies
• Tony Zhang, PhD - Managing Director & Site Head, Lilly Global R&D, China
• Larry Zhu, PhD, MBA - Director, External Scientific Affairs & Business Development, Janssen Pharmaceutical R&D, Asia Pacific

>> 查看会议专题详细日程